One direct listing and four SPACs debuted this week, while five IPOs and four SPACs submitted filings. Japanese software firm Advasa Holdings (ADBT) completed its direct listing on the Nasdaq. The company develops and licenses earned wage access (EWA)...read more
JATT III Acquisition, a blank check company formed by biotech entrepreneurs targeting life sciences businesses, raised $60 million by offering 6 million shares at $10. Unlike most SPACs, the company is not offering units with warrants or rights attached. JATT...read more
Three IPOs and one SPAC priced this week, while two IPOs and five SPACs submitted filings. China-based Londian Wason New Energy Tech (FOIL) priced its upsized US IPO at the top of the range to raise $94 million at a market cap of $1.7 billion ($3.1 billion...read more
JATT III Acquisition, a blank check company formed by biotech entrepreneurs targeting life sciences businesses, filed on Monday with the SEC to raise up to $60 million in an initial public offering. The company plans to raise $60 million by offering 6 million ...read more
US IPO Weekly Recap: Aggreko and four others file papers ahead of Labor Day holiday
One direct listing and four SPACs debuted this week, while five IPOs and four SPACs submitted filings. Japanese software firm Advasa Holdings (ADBT) completed its direct listing on the Nasdaq. The company develops and licenses earned wage access (EWA)...read more
SPAC JATT III Acquisition prices $60 million IPO, targeting biotech and life sciences
JATT III Acquisition, a blank check company formed by biotech entrepreneurs targeting life sciences businesses, raised $60 million by offering 6 million shares at $10. Unlike most SPACs, the company is not offering units with warrants or rights attached. JATT...read more
US IPO Weekly Recap: Copper foils producer and metabolic disorders biotech list amid August lull
Three IPOs and one SPAC priced this week, while two IPOs and five SPACs submitted filings. China-based Londian Wason New Energy Tech (FOIL) priced its upsized US IPO at the top of the range to raise $94 million at a market cap of $1.7 billion ($3.1 billion...read more
SPAC JATT III Acquisition files for a $60 million IPO, following prior SPAC's deal with Talawar Therapeutics
JATT III Acquisition, a blank check company formed by biotech entrepreneurs targeting life sciences businesses, filed on Monday with the SEC to raise up to $60 million in an initial public offering. The company plans to raise $60 million by offering 6 million ...read more